e-therapeutics is latest UK biotech to seek AIM de-listing

e-therapeutics has become the latest UK biotech to say it plans to delist from the Alternative Investment Market (AIM) in another blow to the reputation of the London Stoc

New CEO Mortazavi takes UK biotech e-therapeutics into gene ...

UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen to spearhead the next stage in the company’s development into gen

Novo extends R&D alliance with AI specialist e-Therapeutics

Novo begins R&D tie-up with AI biotech e-Therapeutics

Novo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to find new therapies for type 2 diabetes.

e-Therapeutics and C4XD research Parkinson's drugs

Biotechs search for new treatments for incurable disease

e-Therapeutics CEO steps down

Malcolm Young leaves following trial failure.